6 research outputs found

    Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

    No full text

    Cardiac Amyloidosis: Heterogenous Pathogenic Backgrounds

    No full text

    Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

    No full text
    Background Rosiglitazone is a thiazolidinedione that reduces insulin resistance and might preserve insulin secretion. The aim of this study was to assess prospectively the drugs ability to prevent type 2 diabetes in individuals at high risk of developing the condition
    corecore